Introduction {#sec1}
============

2,3,4-Trisubstituted pyridines are frequently found in biologically active molecules. For instance, the compound **1**([@ref1]) that has a reactivating ability of nerve-agent-inhibited human acetylcholinesterase, anti-inflammatory agent **2**,^[@ref2]^ antifungal agent UK-2A **3**,^[@ref3],[@ref4]^ and anti-influenza agent **4**([@ref5]) contain 2,3,4-trisubstituted pyridines ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

![Biologically active compounds **1**--**4** containing 2,3,4-trisubstituted pyridines (emphasized in red color).](ao-2018-03114b_0007){#fig1}

3-Hydroxy-4-substituted picolinonitrile **5** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) is a valuable synthetic intermediate for 2,3,4-trisubstituted pyridines because the cyano group provides opportunities to construct a variety of functional groups, including amino, methyl,^[@ref6]^ amido,^[@ref7]^ imidate,^[@ref8]^ amidoxime,^[@ref9]^ keto,^[@ref10]^ carboxyl,^[@ref11]^ and ester^[@ref1]^ groups, in only one step. In addition, the 3-hydroxy group provides opportunities to introduce various acyl^[@ref1]^ and alkyl^[@ref12]^ groups in one step. However, the reported synthetic approach for **5** is surprisingly limited. The only reported procedure for the synthesis of **5** includes carbamate formation from 3-hydroxy-picolinonitrile **6**,^[@ref13]−[@ref17]^*ortho*-lithiation of **7**, and subsequent electrophilic trapping of the iodine or formyl group ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, lower route).^[@ref1]^ Unfortunately, this reported procedure (yields in reaction **7** to **5**: 48--53%) requires strong anionic conditions.

![Synthetic Approaches to 3-Hydroxy-4-Substituted Picolinonitrile **5** That Is a Valuable Intermediate for 2,3,4-Trisubstituted Pyridines](ao-2018-03114b_0004){#sch1}

We have reported the functionalization of isoxazole via 4-isoxazolyl magnesium species.^[@ref18]^ This protocol enabled us to synthesize 4-propargylaminoisoxazole **8**, which underwent intramolecular S~E~Ar reaction catalyzed by Au(I) to afford isoxazolopyridines **9**.^[@ref19]^ Here, we report a unique synthetic approach to 3-hydroxy-4-substituted picolinonitriles **5** via isoxazolopyridine formation/N--O bond cleavage sequence. This sequence can be carried out in a one-pot fashion under ambient reaction conditions.

Results and Discussion {#sec2}
======================

It is known that 3- and/or 5-unsubstituted isoxazoles readily occur by N--O bond cleavage under mild basic conditions.^[@ref20],[@ref21]^ De Munno and co-workers reported the mechanism of hydroxide-ion-mediated ring opening of 3-unsubstituted isoxazoles.^[@ref22]^ Houk and co-workers elucidated the mechanism of formate-mediated ring opening of 3-unsubstituted isoxazoles on the basis of theoretical calculations.^[@ref23]^ Both reports supported concerted deprotonation at the 3-position and N--O bond cleavage. On the other hand, acidic cleavage has been much less investigated, and there are only three reports that describe HCl-mediated N--O bond cleavage of 3-unsubstituted isoxazoles.^[@ref24]−[@ref26]^ Although a detailed mechanistic study has not been reported, an acid might activate the oxygen atom of isoxazole ring, and then, a counteranion and/or solvent molecule might abstract a proton at the 3-position.^[@ref23]^ We thought that 3-hydroxy-4-substituted picolinonitriles **5** can be readily synthesized from isoxazolopyridines **9** if N--O bond cleavage of **9** takes place. However, there is no report of N--O bond cleavage of 3-unsubstituted isoxazolopyridines. Therefore, the N--O bond cleavage of previously synthesized isoxazolopyridine **9a**([@ref19]) was first examined under various acidic and basic conditions ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Among Bro̷nsted acid mediated conditions (entries 1--4), aqueous HCl in MeOH conditions (entry 1) afforded **5a** in 70% yield with complete conversion of **9a**. The use of weaker acid, KH~2~PO~4~, resulted in insufficient conversion (entry 2). CH~3~CO~2~H- or CF~3~CO~2~H-mediated conditions improved the conversion but decreased yields (entries 3 and 4). The reaction did not proceed under Lewis acid mediated conditions, such as BF~3~·OEt~2~ (entry 5). Basic conditions tend to afford better results than the acidic conditions (entries 6--11). The use of organic-base-mediated conditions, such as Et~3~N and *N*,*N*-dimethyl-4-aminopyridine (DMAP), afforded **5a** in high yields (entries 6 and 7), whereas sterically bulky 2,6-di-*t*-butyl-4-methylpyridine (DTBMP) resulted in insufficient conversion (entry 8). In the case of 1,4-diazabicyclo\[2.2.2\]octane (DABCO), the reaction proceeded in both methanol and methanol--water media; however, the yields were low (entries 9 and 10). In contrast, the use of inorganic bases afforded good results (entries 11--13). In particular, K~2~CO~3~ in MeOH conditions (entry 13) gave the desired product **5a** in 30 min in 92% yield. Only a trace amount of **5a** was produced in MeOH without any bases or acids, even for a long reaction time (23 h, entry 14).

###### Cleavage of N--O Bond of Isoxazolopyridine **9a** under Acidic and Basic Conditions

![](ao-2018-03114b_0003){#gr4}

  entry    conditions[a](#t1fn1){ref-type="table-fn"}          time (h)   conversion[b](#t1fn2){ref-type="table-fn"} (%)   yield[c](#t1fn3){ref-type="table-fn"} (%)
  -------- --------------------------------------------------- ---------- ------------------------------------------------ -------------------------------------------
  1        aq 1 M HCl/MeOH                                     8          100                                              70
  2        KH~2~PO~4~/MeOH                                     8          46                                               46
  3        CH~3~CO~2~H/MeOH                                    8          62                                               15
  4        CF~3~CO~2~H/MeOH                                    8          82                                               12
  5        BF~3~·OEt~2~/toluene                                8          0                                                0
  6        Et~3~N/MeOH                                         6          100                                              87
  7        DMAP/MeOH                                           6          100                                              96
  8        DTBMP/MeOH                                          6          38                                               37
  9        DABCO/MeOH                                          2          100                                              41
  10       DABCO/H~2~O--MeOH[c](#t1fn3){ref-type="table-fn"}   2          100                                              28
  11       NaOMe/MeOH                                          0.5        100                                              72
  12       NaHCO~3~/MeOH                                       6          100                                              74
  **13**   **K~2~CO~3~/MeOH**                                  **0.5**    **100**                                          **92**[d](#t1fn4){ref-type="table-fn"}
  14       MeOH                                                23         \<10                                             trace

1.5 equiv of acid or base was added.

Conversions and yields were determined by ^1^H NMR analysis using 1,1,2-trichloroethane as an internal standard.

Isolated yield.

H~2~O--MeOH (1:1).

Because the use of K~2~CO~3~ in MeOH accelerated the reaction and produced the desired product in high yield at the shortest reaction time ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 13), the substrate scope of the N--O bond cleavage of isoxazolopyridines was examined under this optimized condition. The results are summarized in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. The 4-alkyl-substituted 3-hydroxypicolinonitriles **9b**--**d** were obtained in high yields. In particular, **9d** containing a sterically bulky *tert*-butyl group was obtained in the highest yield (95%). The 4-aryl-substituted 3-hydroxypicolinonitriles **9e**--**g** containing an electron-donating substituent on the aryl ring were also obtained in high yields (entries 4--6), whereas **9h** containing an electron-withdrawing substituent on the aryl ring was obtained in moderate yield (entry 7). Trimethylsilyl (TMS)-substituted 3-hydroxypicolinonitrile **9i** was also obtained, although the observed yield was moderate (entry 8).

###### Substrate Scope of K~2~CO~3~-Mediated N--O Bond Cleavage of Isoxazolopyridines **9**

![](ao-2018-03114b_0002){#gr5}

  entry   **9**    R                 yield[a](#t2fn1){ref-type="table-fn"} (%)
  ------- -------- ----------------- -------------------------------------------
  1       **9b**   Me                83
  2       **9c**   *n*-pentyl        81
  3       **9d**   *tert*-butyl      95
  4       **9e**   4-MeC~6~H~4~      84
  5       **9f**   4-MeOC~6~H~4~     84
  6       **9g**   3-MeOC~6~H~4~     74
  7       **9h**   4-F~3~CC~6~H~4~   51
  8       **9i**   TMS               53

Isolated yields.

The N--O bond cleavage of isoxazolopyridines **10a**,**10b** with different substitution patterns was examined ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). Both desired products **11a**,**11b** were obtained in good to excellent yields. We already reported the synthesis of **9** and **10** from 4-propargylaminoisoxazole **8** as mentioned before;^[@ref19]^ therefore, we established a unique synthetic approach for various 4-substituted 3-hydroxypicolinonitriles **5** and **11** from the corresponding 4-propargylaminoisoxazoles **8** in two steps. Needless to say, 3,4,5-substituted isoxazolopyridine, such as 3-(4-chlorophenyl)-7-phenylisoxazolo\[4,5-*b*\]pyridine, did not undergo the K~2~CO~3~-mediated N--O bond cleavage, revealing that the deprotonation at C-3 hydrogen is essential to initiate the N--O cleavage in the 3-hydroxypicolinonitrile formation.

![K~2~CO~3~-Mediated N--O Bond Cleavage of Isoxazolopyridines **10**](ao-2018-03114b_0006){#sch2}

If isoxazolopyridine formation and N--O bond cleavage steps can be carried out in a one-pot fashion, synthetic efficiency is further increased. Therefore, one-pot synthesis of 4-substituted 3-hydroxypicolinonitriles **5** from the corresponding 4-propargylaminoisoxazoles **8** was examined using selected substrates ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). The one-pot two-step yield was compared with the stepwise yields calculated from the two isolated yields of **9** and **5**. Various 4-substituted 3-hydroxypicolinonitriles **5** were obtained in a one-pot fashion (entries 1--6). The observed one-pot yields were slightly decreased compared with the stepwise yields (entries 1--4 and 6), whereas an obvious improvement of yield was observed in the case of 4-F~3~CC~6~H~4~-substituted 3-hydroxypicolinonitrile synthesis (entry 5). The intermediate **9h** is labile, and its isolation by silica gel chromatography decreased the yield of **5h**. The isoxazolopyridine bearing a heteroaromatic substituent at the R group (**5j**) was also obtained from the corresponding 4-propargylaminoisoxazole **8j** in 48% yield (entry 7).

###### One-Pot Synthesis of **5** from **8** via Isoxazolopyridine Formation/N--O Bond Cleavage Sequence

![](ao-2018-03114b_0001){#gr6}

  entry   **8**         R                 one-pot yield[a](#t3fn1){ref-type="table-fn"} (%)   stepwise yield[b](#t3fn2){ref-type="table-fn"} (%)
  ------- ------------- ----------------- --------------------------------------------------- ----------------------------------------------------
  1       **8a**        Ph                67                                                  80
  2       **8b**        Me                56                                                  66
  3       **8c**        *n*-pentyl        57                                                  68
  4       **8f**        4-MeOC~6~H~4~     57                                                  71
  5       **8h**        4-F~3~CC~6~H~4~   49                                                  19
  6       **8i**        TMS               22                                                  27
  7       **8j***^c^*   2-thiophenyl      48                                                   

Isolated yields.

The stepwise yields calculated from the two isolated yields of **9** reported in ref ([@ref14]) and **5** shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}.

The stepwise reaction for **8j** was not demonstrated.

Conclusions {#sec3}
===========

In conclusion, one-pot isoxazolopyridine formation/N--O bond cleavage sequence for the synthesis of trisubstituted pyridine **5** was demonstrated. This unique synthetic approach can be carried out under ambient conditions and does not require strong basic conditions. Our developed sequence should be useful as a complementary approach to the conventional one and accelerate the development of drug candidates based on trisubstituted pyridines that can be readily derived from 4-substituted 3-hydroxypicolinonitriles **5**.

Experimental Section {#sec4}
====================

General Experimental Methods {#sec4.1}
----------------------------

NMR spectra were recorded on a Bruker BioSpin AVANCE III (500 and 400 MHz for ^1^H, 125 MHz for ^13^C) instrument in the indicated solvent. Chemical shifts are reported in parts per million (ppm) relative to the signal (0.00 ppm) for internal tetramethylsilane for solutions in CDCl~3~ (7.26 ppm for ^1^H, 77.16 ppm for ^13^C). Multiplicities are reported using the following abbreviations: s, singlet; d, doublet; dd, doublet of doublets; t, triplet; q, quartet; m, multiplet; br, broad; *J*, coupling constants in hertz. IR spectra were recorded on a JASCO FT/IR-4200 spectrometer. Only the strongest and/or structurally important peaks are reported as IR data given in cm^--1^. Mass spectra were measured using a Bruker micrOTOF II. HRMS (ESI-TOF) was calibrated using sodium formate. All reactions were monitored by thin-layer chromatography carried out on 0.2 mm E. Merck silica gel plates (60F-254) with UV light (254 nm). Column chromatography was performed on Silica Gel 60 N, purchased from Fuji Silysia Chemical Ltd. 4-Propargylaminoisoxazoles **8** and isoxazolopyridines **9** and **10** were prepared in accordance with the previously reported procedure.^[@ref19]^ Spectral data for **8i** and **9i** (newly prepared compounds) are shown below.

### *N*-(3-(Trimethylsilyl)prop-2-yn-1-yl)isoxazol-4-amine (**8i**) {#sec4.1.1}

Our previously reported procedure^[@ref19]^ afforded **8i** (101 mg, 0.520 mmol, 52%) as a yellow oil after purification by column chromatography on silica gel (hexane:ethyl acetate = 9:1). ^1^H NMR (500 MHz, CDCl~3~) δ 8.10 (s, 1H), 8.08 (s, 1H), 3.78 (s, 2H), 3.16 (br s, 1H), 0.150 (s, 9H); ^13^C NMR (125 MHz, CDCl~3~) δ 144.6, 141.9, 130.0, 101.9, 89.7, 37.9, 0.1; FTIR (neat): 3340, 2960, 1630, 1251, 844 cm^--1^; HRMS (EI, 70 eV): \[M\]^+^ calcd for C~9~H~14~N~2~OSi, 194.0875; found, 194.0871.

### *N*-(3-(Thiophen-2-yl)prop-2-yn-1-yl)isoxazol-4-amine (**8j**) {#sec4.1.2}

Our previously reported procedure^[@ref19]^ afforded **8j** (84 mg, 0.411 mmol, 48%) as a yellow oil after purification by column chromatography on silica gel (hexane:ethyl acetate = 7:3). ^1^H NMR (500 MHz, CDCl~3~) δ 8.12 (s, 2H), 7.24 (d, *J* = 4.0 Hz, 1H), 7.17 (d, *J* = 2.8 Hz, 1H), 6.95 (t, *J* = 3.6 Hz, 1H), 4.02 (d, *J* = 4.0 Hz, 2H), 3.29 (br s, 1H); ^13^C NMR (125 MHz, CDCl~3~) δ 144.5, 141.8, 132.3, 129.9, 127.4, 127.0, 122.4, 89.3, 77.7, 37.7; FTIR (neat): 3355, 2923, 1626, 1436, 1093 cm^--1^; HRMS (ESI-TOF): *m/z* \[M + Na\]^+^ calcd for C~10~H~8~N~2~NaOS, 227.0255; found, 227.0253.

### 7-(Trimethylsilyl)isoxazolo\[4,5-*b*\]pyridine (**9i**) {#sec4.1.3}

Our previously reported procedure^[@ref19]^ afforded **9i** (8.64 mg, 0.0450 mmol, 45%) as a yellow oil after purification by PTLC (hexane:ethyl acetate = 9:1). ^1^H NMR (500 MHz, CDCl~3~) δ 8.97 (s, 1H), 8.66 (d, *J* = 4.3 Hz, 1H), 7.50 (d, *J* = 4.3 Hz, 1H), 0.467 (s, 9H); ^13^C NMR (125 MHz, CDCl~3~) δ 160.0, 147.6, 147.6, 139.0, 132.0, 128.8, −1.5; FTIR (neat): 2958, 1253, 975, 840, 755 cm^--1^; HRMS (EI, 70 eV): \[M\]^+^ calcd for C~9~H~12~N~2~OSi, 192.0719; found, 192.0721.

General Procedure A for Synthesis of 4-Substituted 3-Hydroxypicolinonitriles **5** and **11** {#sec4.2}
---------------------------------------------------------------------------------------------

To a solution of isoxazolopyridine **9** or **10** (0.100 mmol) in dry MeOH (5.00 mL/mmol of **9** or **10**), K~2~CO~3~ (0.150 mmol) was added. The mixture was stirred at 60 °C for 30 min. The reaction was quenched by addition of 1 M aq HCl. The resultant mixture was extracted with AcOEt, and the combined organic layers were dried over MgSO~4~ and filtered. The solvent was removed in vacuo to give 4-substituted 3-hydroxypicolinonitriles **5** or **11**.

General Procedure B for One-Pot Synthesis of 4-Substituted 3-Hydroxypicolinonitriles **5** from **8** {#sec4.3}
-----------------------------------------------------------------------------------------------------

To a mixture of JohnPhos AuCl (0.05 equiv) and AgSbF~6~ (0.05 equiv) in a sealed vial, *N*-phenylbenzaldimine (1.0 equiv) in 1,2-dichloroethane (2.0 mL/mmol of **8**) was added at room temperature under an argon atmosphere. After the addition of 4-propargylaminoisoxazole **8** in 1,2-dichloroethane (3.0 mL/mmol of **8**), the resultant mixture was stirred at 60 °C for 3 h. To the resultant mixture, dry MeOH (5.0 mL/mmol of **8**) and K~2~CO~3~ (1.5 equiv) were added. The resultant mixture was stirred at 60 °C for 30 min. The reaction was quenched by addition of 1 M aq HCl. The resultant mixture was passed through a pad of celite and extracted with AcOEt, and the combined organic layers were dried over MgSO~4~ and filtered. The solvent was removed in vacuo to give 4-substituted 3-hydroxypicolinonitriles **5**.

### 3-Hydroxy-4-phenylpicolinonitrile (**5a**) {#sec4.3.1}

Procedure A: 92% yield (18.0 mg, 0.0920 mmol). Procedure B: one pot, two steps 67% yield (13.1 mg, 0.0668 mmol). Pale yellow solid; mp 179 °C; ^1^H NMR (500 MHz, CDCl~3~) δ 8.35 (d, *J* = 5.0 Hz, 1H), 7.59--7.49 (m, 5H), 7.41 (d, *J* = 5.0 Hz, 1H); ^13^C NMR (125 MHz, CDCl~3~) δ 153.0, 143.9, 137.4, 132.8, 130.1, 129.9, 128.6, 128.0, 122.2, 115.1; FTIR (neat): 3059, 2985, 2232, 1464, 1210, 1094, 767, 706 cm^--1^; HRMS (ESI-TOF) *m/z* \[M -- H\]^−^ calcd for C~12~H~7~N~2~O, 195.0564; found, 195.0566.

### 3-Hydroxy-4-methylpicolinonitrile (**5b**) {#sec4.3.2}

Procedure A: 83% yield (11.1 mg, 0.0830 mmol). Procedure B: one pot, two steps 56% yield (7.5 mg, 0.056 mmol). Pale yellow solid; mp 155 °C; ^1^H NMR (500 MHz, CDCl~3~) δ 8.20 (d, *J* = 4.5 Hz, 1H), 7.32 (dd, *J* = 4.5, 1.0 Hz, 1H), 6.08 (br s, 1H), 2.36 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~) δ 155.5, 143.5, 136.2, 129.7, 120.3, 115.5, 15.8; FTIR (neat): 2964, 2867, 2697, 2233, 1558, 1478, 1293, 1210, 916 cm^--1^; HRMS (ESI-TOF) *m/z* \[M -- H\]^−^ calcd for C~7~H~5~N~2~O, 133.0407; found, 133.0404.

### 3-Hydroxy-4-pentylpicolinonitrile (**5c**) {#sec4.3.3}

Procedure A: 81% yield (15.4 mg, 0.0810 mmol). Procedure B: one pot, two steps 57% yield (10.9 mg, 0.0574 mmol). Pale yellow solid; mp 171 °C; ^1^H NMR (500 MHz, CDCl~3~) δ 8.19 (d, *J* = 4.5 Hz, 1H), 7.28 (d, *J* = 5.0 Hz, 1H), 6.06 (br s, 1H), 2.68 (t, *J* = 7.5 Hz, 2H), 1.66--1.60 (m, 2H), 1.36--1.33 (m, 4H), 0.91 (t, *J* = 7.0 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~) δ 154.9, 143.9, 140.4, 128.6, 120.4, 115.3, 31.6, 29.4, 28.2, 22.5, 14.1; FTIR (neat): 2956, 2929, 2860, 2233, 1418, 1220 cm^--1^; HRMS (ESI-TOF) *m/z* \[M -- H\]^−^ calcd for C~11~H~13~N~2~O, 189.1033; found, 189.1037.

### 4-(*tert*-Butyl)-3-hydroxypicolinonitrile (**5d**) {#sec4.3.4}

Procedure A: 95% yield (16.7 mg, 0.0950 mmol). Yellow solid; mp 174 °C; ^1^H NMR (500 MHz, CDCl~3~) δ 8.23 (d, *J* = 5.0 Hz, 1H), 7.38 (d, *J* = 4.9 Hz, 1H), 1.42 (s, 9H); ^13^C NMR (125 MHz, CDCl~3~) δ 155.3, 147.2, 144.2, 125.8, 121.5, 115.4, 35.3, 28.7; FTIR (neat): 2962, 2231, 1411, 1225, 1194 cm^--1^; HRMS (ESI-TOF) *m/z* \[M -- H\]^−^ calcd for C~10~H~11~N~2~O, 175.0877; found, 175.0875.

### 3-Hydroxy-4-(*p*-tolyl)picolinonitrile (**5e**) {#sec4.3.5}

Procedure A: 84% yield (17.6 mg, 0.0840 mmol). Pale yellow solid; mp 182 °C; ^1^H NMR (500 MHz, CDCl~3~) δ 8.33 (d, *J* = 4.7 Hz, 1H), 7.39 (m, 5H), 6.04 (br s, 1H), 2.45 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~) δ 153.1, 143.9, 140.5, 137.5, 130.7, 129.7, 128.5, 127.9, 122.0, 115.2, 21.5; FTIR (neat): 3030, 2929, 2232, 1541, 1458, 1234, 817 cm^--1^; HRMS (ESI-TOF) *m/z* \[M -- H\]^−^ calcd for C~13~H~9~N~2~O, 209.0720; found, 209.0720.

### 3-Hydroxy-4-(4-methoxyphenyl)picolinonitrile (**5f**) {#sec4.3.6}

Procedure A: 84% yield (19.0 mg, 0.0840 mmol). Procedure B: one pot, two steps 57% yield (12.8 mg, 0.0566 mmol). Pale yellow solid; mp 187 °C; ^1^H NMR (500 MHz, CDCl~3~) δ 8.31 (d, *J* = 4.5 Hz, 1H), 7.45 (d, *J* = 8.5 Hz, 2H), 7.38 (d, *J* = 4.5 Hz, 1H), 7.07 (d, *J* = 8.5 Hz, 2H), 3.88 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~) δ 161.1, 153.1, 152.7, 143.9, 137.2, 130.0, 127.8, 124.7, 122.0, 115.4, 55.6; FTIR (neat): 2961, 2235, 1609, 1516, 1469, 1281, 1092, 854 cm^--1^; HRMS (ESI-TOF) *m/z* \[M -- H\]^−^ calcd for C~13~H~9~N~2~O~2~, 225.0670; found, 225.0667.

### 3-Hydroxy-4-(3-methoxyphenyl)picolinonitrile (**5g**) {#sec4.3.7}

Procedure A: 74% yield (16.7 mg, 0.0740 mmol). Pale yellow solid; mp 198 °C; ^1^H NMR (500 MHz, CDCl~3~) δ 8.34 (d, *J* = 4.7 Hz, 1H), 7.49 (t, *J* = 8.0 Hz, 1H), 7.40 (d, *J* = 4.7 Hz, 1H), 7.06 (m, 2H), 6.99 (t, *J* = 2.0 Hz, 1H), 6.06 (br s, 1H), 3.87 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~) δ 160.8, 152.9, 143.8, 137.2, 133.9, 131.3, 127.7, 122.2, 120.5, 115.6, 115.1, 114.2, 55.6; FTIR (neat): 2922, 2229, 1583, 1461, 1225, 1033, 696 cm^--1^; HRMS (ESI-TOF) *m/z* \[M -- H\]^−^ calcd for C~13~H~9~N~2~O~2~, 225.0670; found, 225.0666.

### 3-Hydroxy-4-(4-(trifluoromethyl)phenyl)picolinonitrile (**5h**) {#sec4.3.8}

Procedure A: 51% (13.5 mg, 0.051 mmol). Procedure B: one pot, two steps 49% yield (13.0 mg, 0.0492 mmol). Pale yellow solid; mp 161 °C; ^1^H NMR (500 MHz, CDCl~3~) δ 8.38 (d, *J* = 4.5 Hz, 1H), 7.79 (d, *J* = 8.0 Hz, 2H), 7.68 (d, *J* = 8.0 Hz, 2H), 7.44 (d, *J* = 4.5 Hz, 1H), 6.4 (br s, 1H); ^13^C NMR (125 MHz, CDCl~3~) δ 153.1, 144.2, 136.8, 136.4, 132.0 (q, *J*~C--F~ = 32.8 Hz), 129.4, 128.2, 126.4 (q, *J*~C--F~ = 3.7 Hz), 123.8 (q, *J*~C--F~ = 272.7 Hz), 122.4, 114.9; FTIR (neat): 2921, 2851, 2237, 1469, 1321, 1232, 1061, 831 cm^--1^; HRMS (ESI-TOF) *m/z* \[M -- H\]^−^ calcd for C~13~H~6~F~3~N~2~O, 263.0438; found, 263.0440.

### 3-Hydroxy-4-(trimethylsilyl)picolinonitrile (**5i**) {#sec4.3.9}

Procedure A: 53% yield (10.2 mg, 0.0530 mmol). Procedure B: one pot, two steps 22% yield (4.2 mg, 0.022 mmol). Pale yellow solid; mp 175 °C; ^1^H NMR (500 MHz, CDCl~3~) δ 8.26 (d, *J* = 4.5 Hz, 1H), 7.47 (d, *J* = 4.0 Hz, 1H), 6.09 (br s, 1H), 0.35 (s, 9H); ^13^C NMR (125 MHz, CDCl~3~) δ 160.1, 143.3, 138.2, 133.6, 119.6, 115.4, −1.6; FTIR (neat): 2955, 2230, 1398, 1248, 842 cm^--1^; HRMS (ESI-TOF) *m/z* \[M -- H\]^−^ calcd for C~9~H~11~N~2~OSi, 191.0646; found, 191.0646.

### 3-Hydroxy-4-(thiophen-2-yl)picolinonitrile (**5j**) {#sec4.3.10}

Procedure B: one pot, two steps 48% yield (9.6 mg, 0.048 mmol). Yellow solid; mp 192 °C; ^1^H NMR (500 MHz, methanol-*d*~4~) δ 8.07 (d, *J* = 3.6 Hz, 1H), 7.868--7.860 (m, 2H), 7.63 (dd, *J* = 4.0, 3.6 Hz, 1H), 7.18 (dd, *J* = 4.0, 0.8 Hz, 1H); ^13^C NMR (125 MHz, methanol-*d*~4~) δ 156.7, 142.1, 136.5, 134.8, 130.5, 129.1, 128.2, 125.5, 124.0, 117.0; FTIR (neat): 2987, 2232, 1463, 1207, 1092, 703 cm^--1^; HRMS (ESI-TOF) *m/z* \[M--H\]^−^ calcd for C~10~H~5~N~2~OS, 201.0123; found, 201.0123.

### 3-Hydroxy-6-methyl-4-phenylpicolinonitrile (**11a**) {#sec4.3.11}

Pocedure A: 94% yield (19.8 mg, 0.0940 mmol). Yellow solid; mp 204 °C; ^1^H NMR (500 MHz, CDCl~3~) δ 7.52 (m, 5H), 7.26 (s, 1H), 2.55 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~) δ 152.9, 151.3, 137.9, 133.1, 130.0, 129.8, 128.6, 128.1, 120.8, 115.3, 23.6; FTIR (neat): 3648, 3210, 2965, 2867, 2726, 2230, 1698, 1541, 1256, 1019, 700 cm^--1^; HRMS (ESI-TOF) *m/z* \[M -- H\]^−^ calcd for C~13~H~9~N~2~O, 209.0720; found, 209.0719.

### 1-Hydroxy-5-phenylbenzo\[*f*\]isoquinoline-2-carbonitrile (**11b**) {#sec4.3.12}

Pocedure A: 75% yield (22.2 mg, 0.0750 mmol). Yellow solid; mp 210 °C; ^1^H NMR (500 MHz, CDCl~3~) δ 9.68 (m, 1H), 8.90 (s, 1H), 8.00 (m, 1H), 7.98 (1H, s), 7.82 (m, 2H), 7.52 (m, 5H); ^13^C NMR (125 MHz, CDCl~3~) δ 155.5, 144.8, 138.5, 137.3, 133.8, 133.6, 130.3, 130.2, 129.5, 129.4, 129.1, 128.9, 128.5, 128.4, 127.7, 124.5, 116.4, 115.4; FTIR (neat): 2926, 2224, 1714, 1425, 1216, 756, 703 cm^--1^; HRMS (ESI-TOF) *m/z* \[M -- H\]^−^ calcd for C~20~H~11~N~2~O, 295.0877; found, 295.0878.
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